, India and Brazil will enjoy leading growth rate in 2012, with China expected to continue its double digit growth similar to 2011, due to an increase in the Chinese Government's expenditure and individual consumer spending. With the rise in number of affluent Chinese population, diseases such as cancer, diabetes and cardiovascular ailments are on the rise, enhancing the demand for drug development targeted towards the domestic Chinese market.
Revenue expected to sustain growth levels
Optimism regarding revenue growth of global pharmaceutical manufacturers, CROs and CMOs remained stable in 2011 and decreased marginally in 2012. However, it is projected that revenue expectations in both emerging and recovering developed markets will sustain growth levels in 2012.
Reduction in drug costs
Following the global financial crisis in 2008–2009, and the subsequent European debt crisis in 2011, global pharmaceutical manufacturing companies have accelerated their focus to reduce the cost of drugs leading to a renewed evaluation of opportunities in the outsourcing of manufacturing activities. These incidents favor the growth of the pharmaceutical market in emerging economies and also present opportunities for CROs and CMOs.
Sanofi Aventis, Gen-Probe Incorporated, Neumedicines, RxBio, Araim Pharmaceuticals of Ossining and Cellerant Therapeutics, Pfizer, Tibet Pharmaceuticals, Anhui Taihe Pharmaceutical Group, BioMarin Pharmaceutical, Abbott, Catalent Pharma Solutions, Vitamin Shoppe, OncoSec Medical, Quintiles, QPS, Neptune Technologies and Bioressources, Sartorius Stedim Biotech, Bosch Packaging Technology, Sanner, Bristol-Myers Squibb, Micromet, Amgen, OPKO Health USA, ALS Distribuidora Limitada, UCB Pharma, Astellas Pharma Inc, UCB Pharmaand Nodality, INC Research LLC, Trident Clinical Research, Accelrys, VelQuest, Indoco Remedies, DSM, Mylan Inc,Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Related medicine technology :1
. Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry2
. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)3
. Cambrex To Present At Jefferies 2012 Global Healthcare Conference4
. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis5
. Bausch + Lomb Names John Barr Global President Surgical6
. UBM Canon, the Global MedTech Authority, Announces Strategic Alliance with ITG Market Research, a Preeminent Industry Research Organization7
. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets8
. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 20159
. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies10
. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations11
. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report